Vaulting Forth the Vaccine

Boston - Cancer researchers have developed an experimental vaccine that showed promising results in early stage testing for the treatment of metastatic melanoma. The vaccine, which is made by transferring a gene into a patient's own melanoma cells, caused an immune system attack against melanoma tumors, with nearly one-third of 35 patients alive after three years, and four of them with no signs of the disease.